Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
Marie E FaughnanJohannes J MagerSteven W HettsValerie A PaldaKelly Lang-RobertsonElisabetta BuscariniErik DeslandresRaj S KasthuriAndrea LausmanDavid PoetkerFelix A RatjenMark S ChesnuttMarianne S ClancyKevin J WhiteheadDavid J KuterMurali M ChakinalaMiles B ConradDaniel CortesClaudia CrocioneJama DarlingEls de GussemCarol DerksenSophie Dupuis-GirodPatrick FoyUrban W GeisthoffJames R GossageAdrienne M HammilllKetil HeimdalKatharine HendersonVivek N IyerAnette Drøhse KjeldsenMasaki KomiyamaKevin KorenblattJamie McDonaldJack McMahonJustin P McWilliamsMary E MeekMeir Mei ZahavScott OlitskySara PalmerRose PantaloneJay F PiccirilloBeth PlahnMary E M PorteousMarco C PostIvan RadovanovicPaul J RochonJosanna Rodriguez-LopezCarlo SabbaMarcelo Martín SerraClaire L ShovlinDennis SprecherAndrew J WhiteIngrid WinshipRoberto ZarrabeitiaPublished in: Annals of internal medicine (2020)
The expert panel generated and approved 6 new recommendations for each of the following 6 priority topic areas: epistaxis, gastrointestinal bleeding, anemia and iron deficiency, liver VMs, pediatric care, and pregnancy and delivery (36 total). The recommendations highlight new evidence in existing topics from the first International HHT Guidelines and provide guidance in 3 new areas: anemia, pediatrics, and pregnancy and delivery. These recommendations should facilitate implementation of key components of HHT care into clinical practice.